by The transcutaneous electrical nerve stimulation (TENS) market is witnessing trends of growing demand for non-invasive and drug-free pain relief options. TENS devices provide mild electrical pulses to nerves for pain management without the need for medication. Growing prevalence of chronic pain disorders such as lower back pain, arthritis, and neurological conditions has fueled the demand for transcutaneous electrical nerve stimulation globally.
TENS devices employ the principle of gate control theory to provide relief from various acute and chronic pain conditions. The device is placed on the skin surface over the painful area and mild electrical pulses are administered to stimulate peripheral nerves for inhibiting pain sensation transmission to the brain. TENS provides a safe, convenient and drug-free option for pain management and is increasingly being used as the first line of treatment for lower back pain, arthritis, sports injuries and post-surgical pain relief.
The global transcutaneous electrical nerve stimulation market is estimated to be valued at US$ 5.23 Bn in 2024 and is expected to exhibit a CAGR of 4.2% over the forecast period 2024 to 2031.
Key Takeaways
Growing prevalence of chronic pain disorders such as lower back pain, osteoarthritis, and migraine is a key factor driving the demand for Transcutaneous Electrical Nerve Stimulation Market Size devices globally. TENS offers a drug-free solution for chronic pain relief and finds increasing adoption among healthcare providers and patients.
In terms of geography, North America represents the largest market for transcutaneous electrical nerve stimulation devices followed by Europe and Asia Pacific. However, the transcutaneous electrical nerve stimulation market is witnessing rapid growth in developing economies of Asia Pacific and Latin America with rising healthcare expenditure and growing awareness about non-invasive pain management therapies.
Key players operating in the Transcutaneous Electrical Nerve Stimulation Market Size are Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Omron Healthcare, Inc., Nevro Corp., DJO Global, Inc., Zynex Medical, COMPex, ITO Co., Ltd., Beurer GmbH, BTL, Chattanooga International, EMS Physio Ltd., BioMedical Life Systems, Inc., Current Solutions, LLC, Zewa, Inc., Walgreen Co., Pain Management Technologies, Inc., OPTP, and Roscoe Medical.
Market Key Trends
The transcutaneous electrical nerve stimulation market is witnessing a key trend of technological advancements in product design. New device features such as smaller size, lightweight, rechargeable battery, customized stimulation programs, wireless connectivity etc. are improving patient comfort and compliance. Manufacturers are also developing self-adhesive TENS devices that can be easily placed over painful areas by patients themselves and do not require the intervention of a healthcare provider. This is increasing the accessibility of TENS therapy globally. Efforts towards expanding insurance coverage for TENS devices especially post-surgical pain relief and chronic pain conditions will continue to strengthen the demand for transcutaneous electrical nerve stimulation market over the forecast period.
Porter’s Analysis
Threat of new entrants: The Transcutaneous Electrical Nerve Stimulation Market is difficult to penetrate requiring high R&D investments and established distribution networks.
Bargaining power of buyers: Buyers have moderate bargaining power as there are few competitors offering substitutes for pain therapy and neuromodulation.
Bargaining power of suppliers: Suppliers have low bargaining power as key components are widely available from alternative suppliers.
Threat of new substitutes: Substitutes like opioids, acupuncture and biofeedback have some threat. However, TENS provide a non-invasive drug-free option for pain relief.
Competitive rivalry: Market is competitive with growth and acquisitions by large players to increase their product portfolios.
Geographical Regions
North America accounts for the major share in the transcutaneous electrical nerve stimulation market in terms of value due to rising prevalence of chronic pain disorders, neurological conditions and favorable reimbursement policies. Asia Pacific is projected to witness the fastest growth during the forecast period driven by rapidly aging population, growing healthcare expenditures and increasing acceptance of neurostimulation therapy.
Europe holds the second largest share of the market after North America due to growing adoption of pain management therapies and rising R&D investments by key players. Japan and China contribute significantly to the Asia Pacific market backed by improving healthcare infrastructure, rising disposable incomes and increasing focus on pain relief therapies. Latin America and Middle East & Africa provide promising growth opportunities for TENS manufacturers due to lack of awareness about advanced pain therapies in regional markets.
About Author:
Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
